The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein

Cancer Cell

Volumn 8, Issue 5, 2005, Pages 355-368

  Neviani, Paolo ^a   Santhanam, Ramasamy ^a   Trotta, Rossana ^a   Notari, Mario ^a   Blaser, Bradley W ^b   Liu, Shujun ^b   Mao, Hsiaoyin ^b   Chang, Ji Suk ^a   Galietta, Annamaria ^a   Uttam, Ashwin ^a   Roy, Denis C ^c   Valtieri, Mauro ^d   Bruner Klisovic, Rebecca ^b   Caligiuri, Michael A ^a,b,e   Bloomfield, Clara D ^b,e   Marcucci, Guido ^a,b,e   Perrotti, Danilo ^a,e  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c UNIVERSITY OF MONTREAL   (Canada)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; FORSKOLIN; IMATINIB; PHOSPHOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN SET; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLAST CELL CRISIS; BLAST TRANSFORMATION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CLONOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; GENE INACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; STEM CELL; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 27644569730     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.10.015     Document Type: Article

References (56)

1. K.C. Agarwal, and R.E. Parks Jr. Forskolin: a potential antimetastatic agent Int. J. Cancer 32 1983 801 804
2. D. Avni, H. Yang, F. Martelli, F. Hofmann, W.M. ElShamy, S. Ganesan, R. Scully, and D.M. Livingston Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage Mol. Cell 12 2003 735 746
3. Z. Baharians, and A.H. Schonthal Reduction of Ha-ras-induced cellular transformation by elevated expression of protein phosphatase type 2A Mol. Carcinog. 24 1999 246 254
4. D.J. Barnes, B. Schultheis, S. Adedeji, and J.V. Melo Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemia Oncogene 24 2005 6432 6440
5. B. Calabretta, and D. Perrotti The biology of CML blast crisis Blood 103 2004 4010 4022
6. S.G. Carlson, E. Eng, E.G. Kim, E.J. Perlman, T.D. Copeland, and B.J. Ballermann Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor J. Am. Soc. Nephrol. 9 1998 1873 1880
7. J. Chen, B.L. Martin, and D.L. Brautigan Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation Science 257 1992 1261 1264
8. C.W. Chiang, C. Kanies, K.W. Kim, W.B. Fang, C. Parkhurst, M. Xie, T. Henry, and E. Yang Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis Mol. Cell. Biol. 23 2003 6350 6362
9. D. Cortez, G. Reuther, and A.M. Pendergast The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells Oncogene 15 1997 2333 2342
10. N.C. Cross, L. Feng, A. Chase, J. Bungey, T.P. Hughes, and J.M. Goldman Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation Blood 82 1993 1929 1936
11. H.G. Derigs, D. Klingberg, G.J. Tricot, and H.S. Boswell Effector function for RAS oncogene in interleukin-3-dependent myeloid cells involves diminished efficacy of prostaglandin E1-mediated inhibition of proliferation Blood 74 1989 1942 1951
12. X. Ding, and J.L. Staudinger Induction of drug metabolism by forskolin: the role of the pregnane X receptor and the protein kinase a signal transduction pathway J. Pharmacol. Exp. Ther. 312 2005 849 856
13. A.H. Elmaagacli, D.W. Beelen, B. Opalka, S. Seeber, and U.W. Schaefer The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage Ann. Hematol. 79 2000 424 431
14. Z. Fan, P.J. Beresford, D.Y. Oh, D. Zhang, and J. Lieberman Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor Cell 112 2003 659 672
15. M.S. Feschenko, E. Stevenson, A.C. Nairn, and K.J. Sweadner A novel cAMP-stimulated pathway in protein phosphatase 2A activation J. Pharmacol. Exp. Ther. 302 2002 111 118
16. M. Fornerod, J. Boer, S. van Baal, M. Jaegle, M. von Lindern, K.G. Murti, D. Davis, J. Bonten, A. Buijs, and G. Grosveld Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements Oncogene 10 1995 1739 1748
17. A. Gaiger, T. Henn, E. Horth, K. Geissler, G. Mitterbauer, T. Maier-Dobersberger, H. Greinix, C. Mannhalter, O.A. Haas, and K. Lechner Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression Blood 86 1995 2371 2378
18. N. Gomez, and P. Cohen Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases Nature 353 1991 170 173
19. K.B. Gutzkow, S. Naderi, and H.K. Blomhoff Forskolin-mediated G1 arrest in acute lymphoblastic leukaemia cells: phosphorylated pRB sequesters E2Fs J. Cell Sci. 115 2002 1073 1082
20. T. Hunter Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling Cell 80 1995 225 236
21. A. Iervolino, G. Santilli, R. Trotta, C. Guerzoni, V. Cesi, A. Bergamaschi, C. Gambacorti-Passerini, B. Calabretta, and D. Perrotti hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis Mol. Cell. Biol. 22 2002 2255 2266
22. C.H. Jamieson, L.E. Ailles, S.J. Dylla, M. Muijtjens, C. Jones, J.L. Zehnder, J. Gotlib, K. Li, M.G. Manz, and A. Keating Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML N. Engl. J. Med. 351 2004 657 667
23. V. Janssens, and J. Goris Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling Biochem. J. 353 2001 417 439
24. V. Janssens, J. Goris, and C. Van Hoof PP2A: the expected tumor suppressor Curr. Opin. Genet. Dev. 15 2005 34 41
25. C. Kamibayashi, R.L. Lickteig, R. Estes, G. Walter, and M.C. Mumby Expression of the A subunit of protein phosphatase 2A and characterization of its interactions with the catalytic and regulatory subunits J. Biol. Chem. 267 1992 21864 21872
26. M. Kozlowski, I. Mlinaric-Rascan, G.S. Feng, R. Shen, T. Pawson, and K.A. Siminovitch Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice J. Exp. Med. 178 1993 2157 2163
27. M. Li, A. Makkinje, and Z. Damuni The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A J. Biol. Chem. 271 1996 11059 11062
28. M. Liedtke, P. Pandey, S. Kumar, S. Kharbanda, and D. Kufe Regulation of Bcr-Abl-induced SAP kinase activity and transformation by the SHPTP1 protein tyrosine phosphatase Oncogene 17 1998 1889 1892
29. Y.M. Lim, S. Wong, G. Lau, O.N. Witte, and J. Colicelli BCR/ABL inhibition by an escort/phosphatase fusion protein Proc. Natl. Acad. Sci. USA 97 2000 12233 12238
30. L. Lu, K. Welte, J.L. Gabrilove, G. Hangoc, E. Bruno, R. Hoffman, and H.E. Broxmeyer Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures Cancer Res. 46 1986 4357 4361
31. E.Y. Moon, and A. Lerner PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A Blood 101 2003 4122 4130
32. S.G. O'Brien, F. Guilhot, R.A. Larson, I. Gathmann, M. Baccarani, F. Cervantes, J.J. Cornelissen, T. Fischer, A. Hochhaus, and T. Hughes Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia N. Engl. J. Med. 348 2003 994 1004
33. M.K. Pathak, and T. Yi Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines J. Immunol. 167 2001 3391 3397
34. D. Perrotti, S. Bonatti, R. Trotta, R. Martinez, T. Skorski, P. Salomoni, E. Grassilli, R.V. Lozzo, D.R. Cooper, and B. Calabretta TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis EMBO J. 17 1998 4442 4455
35. D. Perrotti, V. Cesi, R. Trotta, C. Guerzoni, G. Santilli, K. Campbell, A. Iervolino, F. Condorelli, C. Gambacorti-Passerini, M.A. Caligiuri, and B. Calabretta BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2 Nat. Genet. 30 2002 48 58
36. G. Rimon, and M. Rubin Regulation of a common, low-affinity binding site for primary prostanoids on bovine aortic endothelial cells Biochim. Biophys. Acta 1380 1998 289 296
37. S. Sato, N. Fujita, and T. Tsuruo Modulation of Akt kinase activity by binding to Hsp90 Proc. Natl. Acad. Sci. USA 97 2000 10832 10837
38. C.L. Sawyers, A. Hochhaus, E. Feldman, J.M. Goldman, C.B. Miller, O.G. Ottmann, C.A. Schiffer, M. Talpaz, F. Guilhot, and M.W. Deininger Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study Blood 99 2002 3530 3539
39. G. Saydam, H.H. Aydin, F. Sahin, N. Selvi, G. Oktem, E. Terzioglu, F. Buyukkececi, and S.B. Omay Involvement of protein phosphatase 2A in interferon-α-2b-induced apoptosis in K562 human chronic myelogenous leukaemia cells Leuk. Res. 27 2003 709 717
40. A.H. Schonthal Role of serine/threonine protein phosphatase 2A in cancer Cancer Lett. 170 2001 1 13
41. K. Seamon, and J.W. Daly Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein J. Biol. Chem. 256 1981 9799 9801
42. S.B. Seo, P. McNamara, S. Heo, A. Turner, W.S. Lane, and D. Chakravarti Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein Cell 104 2001 119 130
43. N.P. Shah, and C.L. Sawyers Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias Oncogene 22 2003 7389 7395
44. E. Sontag Protein phosphatase 2A: the Trojan Horse of cellular signaling Cell. Signal. 13 2001 7 16
45. R. Taetle, and S. Li-en Further studies on mechanisms of abnormal prostaglandin response by chronic myelogenous leukaemia granulocyte/macrophage progenitors Leuk. Res. 8 1984 833 842
46. S.A. Tenenbaum, P.J. Lager, C.C. Carson, and J.D. Keene Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays Methods 26 2002 191 198
47. R. Trotta, T. Vignudelli, O. Candini, R.V. Intine, L. Pecorari, C. Guerzoni, G. Santilli, M.W. Byrom, S. Goldoni, and L.P. Ford BCR/ABL activates mdm2 mRNA translation via the La antigen Cancer Cell 3 2003 145 160
48. G.L. Wang, P. Iakova, M. Wilde, S. Awad, and N.A. Timchenko Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBPα growth inhibitory activity Genes Dev. 18 2004 912 925
49. S. Wera, A. Fernandez, N.J. Lamb, P. Turowski, M. Hemmings-Mieszczak, R.E. Mayer-Jaekel, and B.A. Hemmings Deregulation of translational control of the 65-kDa regulatory subunit (PR65α) of protein phosphatase 2A leads to multinucleated cells J. Biol. Chem. 270 1995 21374 21381
50. S. Wong, and O.N. Witte The BCR-ABL story: bench to bedside and back Annu. Rev. Immunol. 22 2004 247 306
51. S. Xie, H. Lin, T. Sun, and R.B. Arlinghaus Jak2 is involved in c-Myc induction by Bcr-Abl Oncogene 21 2002 7137 7146
52. S.I. Yang, R.L. Lickteig, R. Estes, K. Rundell, G. Walter, and M.C. Mumby Control of protein phosphatase 2A by simian virus 40 small-t antigen Mol. Cell. Biol. 11 1991 1988 1995
53. K. Yasui, B. Hu, T. Nakazawa, K. Agematsu, and A. Komiyama Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition J. Clin. Invest. 100 1997 1677 1684
54. E. Yeh, M. Cunningham, H. Arnold, D. Chasse, T. Monteith, G. Ivaldi, W.C. Hahn, P.T. Stukenberg, S. Shenolikar, and T. Uchida A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells Nat. Cell Biol. 6 2004 308 318
55. N. Yokoyama, and W.T. Miller Inhibition of Src by direct interaction with protein phosphatase 2A FEBS Lett. 505 2001 460 464
56. N. Yokoyama, N.C. Reich, and W.T. Miller Involvement of protein phosphatase 2A in the interleukin-3-stimulated Jak2-Stat5 signaling pathway J. Interferon Cytokine Res. 21 2001 369 378